Intracellular TLR signaling: A structural perspective on human disease

被引:38
作者
Lasker, Michael V.
Nair, Satish K.
机构
[1] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA
[2] Univ Illinois, Med Scholars Program, Urbana, IL 61801 USA
[3] Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA
关键词
D O I
10.4049/jimmunol.177.1.11
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
TLRs are crucial sensors of microbial infection. Maintaining structural integrity of TLR signaling components is essential for subsequent immunological protection. Alterations to the structure of these signaling molecules are often associated with profound clinical outcomes and susceptibility to various infectious diseases. These changes in structure are sometimes the result of a single nucleotide polymorphism (SNP). Numerous SNPs have been found in components of the TLR signaling pathway. Recently, the medical consequences and effects on TLR signaling of several of these SNPs have been elucidated. In addition, there have been numerous structures solved that are important to our understanding of the TLR signaling pathway at the molecular level. The scope of this review is to tie together current structural, biochemical, and genetic information of TLR signaling.
引用
收藏
页码:11 / 16
页数:6
相关论文
共 50 条
[1]   A low molecular weight mimic of the Toll/IL-1 receptor/resistance domain inhibits IL-1 receptor-mediated responses [J].
Bartfai, T ;
Behrens, MM ;
Gaidarova, S ;
Pemberton, J ;
Shivanyuk, A ;
Rebek, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (13) :7971-7976
[2]   Intracellular localization of Toll-like receptor 9 prevents recognition of self DNA but facilitates access to viral DNA [J].
Barton, GM ;
Kagan, JC ;
Medzhitov, R .
NATURE IMMUNOLOGY, 2006, 7 (01) :49-56
[3]   The molecular structure of the Toll-like receptor 3 ligand-binding domain [J].
Bell, JK ;
Botos, I ;
Hall, PR ;
Askins, J ;
Shiloach, J ;
Segal, DM ;
Davies, DR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (31) :10976-10980
[4]   Cutting edge: A toll-like receptor 2 polymorphism that is associated with lepromatous leprosy is unable to mediate mycobacterial signaling [J].
Bochud, PY ;
Hawn, TR ;
Aderem, A .
JOURNAL OF IMMUNOLOGY, 2003, 170 (07) :3451-3454
[5]   Inhibition of interleukin 1 receptor/toll-like receptor signaling through the alternatively spliced, short form of MyD88 is due to its failure to recruit IRAK-4 [J].
Burns, K ;
Janssens, S ;
Brissoni, B ;
Olivos, N ;
Beyaert, R ;
Tschopp, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (02) :263-268
[6]   MyD88, an adapter protein involved in interleukin-1 signaling [J].
Burns, K ;
Martinon, F ;
Esslinger, C ;
Pahl, H ;
Schneider, P ;
Bodmer, JL ;
Di Marco, F ;
French, L ;
Tschopp, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (20) :12203-12209
[7]   IRAK: A kinase associated with the interleukin-1 receptor [J].
Cao, ZD ;
Henzel, WJ ;
Gao, XO .
SCIENCE, 1996, 271 (5252) :1128-1131
[8]  
Choe J, 2005, SCIENCE, V309, P581, DOI 10.1126/science.1115253
[9]   Structural complementarity of Toll/interleukin-1 receptor domains in toll-like receptors and the adaptors Mal and MyD88 [J].
Dunne, A ;
Ejdebäck, M ;
Ludidi, PL ;
O'Neill, LAJ ;
Gay, NJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (42) :41443-41451
[10]  
Edwards DN, 1997, DEVELOPMENT, V124, P3855